Literature DB >> 2162541

Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors.

R W Derlet1, T E Albertson.   

Abstract

Agents which interact with alpha- or beta-adrenoceptors were evaluated for efficacy in preventing seizures and death from a lethal dose of cocaine. Rats were first pretreated with the test drug(s), then subjected to an intraperitoneal LD86 of cocaine (70 mg/kg). In this model, control vehicle-pretreated animals developed seizures within six minutes, followed by death within 10 minutes. Significant protection against death was afforded by pretreatment with clonidine (0.25 mg/kg), prazocin (5.0 to 20 mg/kg), propranolol (8.0 to 32 mg/kg), or labetalol (40 mg/kg). Surviving animals still experienced seizures as judged through behavior and EEG recordings. Phentolamine did not affect the incidence of seizures or death. Two nonadrenoceptor agents were also studied: hydralazine reduced the incidence of death and seizures at 5.0 and 10 mg/kg, but reserpine did not alter the incidence of death or seizures. A combination of prazocin and propranolol did not provide additional protection compared to single agents. We conclude that the pathogenesis of acute cocaine death is complex, and that this toxicity can be antagonized by agents having either central or peripheral effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162541     DOI: 10.1016/0091-3057(90)90395-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.

Authors:  D Kenny; P S Pagel; D C Warltier
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

2.  A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity.

Authors:  Murat Seyit; Bulent Erdur; Selim Kortunay; Aykut Yuksel; Atakan Yilmaz; Mert Ozen; Aykut Uyanik; Onder Tomruk; Ahmet Ergin
Journal:  Iran Red Crescent Med J       Date:  2015-06-01       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.